Back
ARS Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
SPRY
ARS Pharmaceuticals, Inc.
Last Price:
$9.30
Seasonality Move:
-2.51%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARS Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.28 | Buy |
| 20-day SMA: | 9.58 | Sell |
| 50-day SMA: | 10.42 | Sell |
| 200-day SMA: | 12.18 | Sell |
| 8-day EMA: | 7.66 | Buy |
| 20-day EMA: | 4.66 | Buy |
| 50-day EMA: | 2.26 | Buy |
| 200-day EMA: | 0.63 | Buy |
ARS Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.52 | Buy |
| Relative Strength Index (14 RSI): | 44.24 | Sell |
| Chaikin Money Flow: | 505305 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.22 - 10.26) | Sell |
| Bollinger Bands (100): | (8.77 - 11.05) | Sell |
ARS Pharmaceuticals, Inc. Technical Analysis
| Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 12 | 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ARS Pharmaceuticals, Inc. Stock
Is ARS Pharmaceuticals, Inc. Stock a Buy?
-
ARS Pharmaceuticals, Inc. share price is 9.34 while SPRY 8-day simple moving average is 9.28, which is a Buy signal.
-
The stock price of SPRY is 9.34 while ARS Pharmaceuticals, Inc. 20-day SMA is 9.58, which makes it a Sell.
-
ARS Pharmaceuticals, Inc. 50-day simple moving average is 10.42 while SPRY share price is 9.34, making it a Sell technically.
-
SPRY stock price is 9.34 and ARS Pharmaceuticals, Inc. 200-day simple moving average is 12.18, creating a Sell signal.
SPRY Technical Analysis vs Fundamental Analysis
Sell
38
ARS Pharmaceuticals, Inc. (SPRY)
is a Sell
Is ARS Pharmaceuticals, Inc. a Buy or a Sell?
-
ARS Pharmaceuticals, Inc. stock is rated a SellThe current ARS Pharmaceuticals, Inc. [SPRY] share price is $9.34. The Score for SPRY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
ARS Pharmaceuticals, Inc. Stock Info
Market Cap:
923.2M
Price in USD:
9.34
Share Volume:
942.3K
ARS Pharmaceuticals, Inc. 52-Week Range
52-Week High:
18.90
52-Week Low:
6.66
Sell
38
ARS Pharmaceuticals, Inc. (SPRY)
is a Sell
ARS Pharmaceuticals, Inc. Share Price Forecast
-
What is the ARS Pharmaceuticals, Inc. stock price today?The ARS Pharmaceuticals, Inc. stock price is 9.34 USD today.
-
Will SPRY stock go up or go down?ARS Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is ARS Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ARS Pharmaceuticals, Inc. is overvalued.
Is ARS Pharmaceuticals, Inc. Stock a Buy?
-
ARS Pharmaceuticals, Inc. share price is 9.34 while SPRY 8-day exponential moving average is 7.66, which is a Buy signal.
-
The stock price of SPRY is 9.34 while ARS Pharmaceuticals, Inc. 20-day EMA is 4.66, which makes it a Buy.
-
ARS Pharmaceuticals, Inc. 50-day exponential moving average is 2.26 while SPRY share price is 9.34, making it a Buy technically.
-
SPRY stock price is 9.34 and ARS Pharmaceuticals, Inc. 200-day simple moving average is 0.63, creating a Buy signal.
Fundamental Analysis of ARS Pharmaceuticals, Inc.
Is ARS Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $0.89 per share.
Technical Analysis of ARS Pharmaceuticals, Inc.
Should I short ARS Pharmaceuticals, Inc. stock?
-
SPRY Moving Average Covergence Divergence (MACD) indicator is 2.52, suggesting ARS Pharmaceuticals, Inc. is a Buy
-
ARS Pharmaceuticals, Inc. Relative Strength Index (RSI) is 44.24, which suggest ARS Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for ARS Pharmaceuticals, Inc. is (9.22 - 10.26), which suggest ARS Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for ARS Pharmaceuticals, Inc. is (8.77 - 11.05), which suggest ARS Pharmaceuticals, Inc. is a Sell
* ARS Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.